NMPA Approval

Recombinant Coagulation Factor VIII for Injection

Approval Number

国药准字SJ20170022

Registration Date

December 20, 2023

Previous Approval Numbers

S20170022

Drug Information

Generic Name

注射用重组人凝血因子Ⅷ

Trade Name

百因止

Dosage Form

注射剂

Strength

1000IU/瓶

Drug Type

生物制品

Registration Date

December 20, 2023

Expiry Date

July 28, 2027

Company Address

Industriestrasse 67, A-1221 Vienna, Austria

Company Address

Route de Pierre-à-Bot 111,2000 Neuchatel, Switzerland

Empowering clinical research with data-driven insights and AI-powered tools.

注射用重组人凝血因子Ⅷ - NMPA 批准文号 | MedPath